The survival and development of each organism relies on the equal partitioning of its genome during cell division. Errors in this process can lead to severe developmental defects and cancer in humans. Key for the accurate distribution of the genome is the mitotic spindle composed of dynamic microtubules (Mts). [1] The shape and function of the mitotic spindle depends on the concerted action of various kinesins, these are molecular motor proteins which as microtubule-stimulated ATPases convert chemical energy into mechanical force. Recently, we identified the kinesin-8 member Kif18A as a central component for the correct alignment of chromosomes at the spindle equator. [2] Furthermore, in vitro analyses revealed that Kif18A distinguishes itself from all other kinesins by its dual functionality: motility and depolymerase activity. [2] [3] [4] Owing to their fast and often reversible mode of action, small molecules are ideally suited to dissect the function and mechanism of proteins. Given the complex enzymatic characteristics of Kif18A, we set up a smallmolecule screen to identify inhibitors of Kif18A. Herein we report the discovery of BTB-1 (Figure 1 a) , the first smallmolecule inhibitor of Kif18A. We show that BTB-1 potently inhibits the ATPase activity of Kif18A (IC 50 = 1.69 mm) but not of other tested key mitotic kinesins. BTB-1 blocks the motility of Kif18A in a reversible manner. Notably, BTB-1 inhibits Kif18A in an adenosine triphosphate(ATP)-competitive but microtubule-uncompetitive manner and slows down the progression of cells through mitosis.
To identify Kif18A inhibitors, we screened a 9000 member library of diverse small molecules for compounds that inhibit in vitro the ATPase activity of the recombinant motordomain of Kif18A (GST-Kif18A motor ; GST = glutathion-S-transferase). The release of free phosphate as determined by a malachite green-based assay was used as readout for the activity of GST-Kif18A motor (see Supporting Information). Compounds were screened in duplicate at a concentration of about 50 mm and considered as "hits" if they inhibited the Kif18A motor -mediated ATP hydrolysis by more than 65 %. Of the identified four hits, BTB-1 (Figure 1 a) was the most potent and selective and, thus, selected for further analyses. To determine the IC 50 we used an enzyme-coupled assay to measure the rate of ATP hydrolysis by recombinant HisKif18A motor in the presence of Mts and increasing concentrations of BTB-1 or DMSO as solvent control (see Supporting Information). BTB-1 greatly inhibited the Mt-stimulated ATPase activity of His-Kif18A motor with an IC 50 of 1.69 mm (Figure 1 b) . Thus, BTB-1 is the first inhibitor for Kif18A, a key enzyme essential for proper chromosome segregation in eukaryotes ranging from yeast to human. To confirm the chemical identity of BTB-1, the molecule was re-synthesized (see Supporting Information). The re-synthesized BTB-1 was equally potent in inhibiting His-Kif18A motor (IC 50 = 1.86 mm ; Figure 1 b). Next, we addressed the specificity of BTB-1. Importantly, our studies showed that 100 mm BTB-1 did not significantly inhibit any of the other tested mitotic kinesins (Figure 1 c) .
To gain insights into the mode of action of BTB-1, we analyzed whether BTB-1 affects Kif18A in a reversible manner. To this end, we established an in vitro Mt gliding assay using a flow chamber which allows us to quickly exchange the solution of the reaction. The movement of Mts was recorded by time-lapse microscopy and displayed by a kymograph in which the position of an individual Mt (horizontal axis) is plotted as a function of time (vertical axis) as shown in Figure 2 . In the presence of DMSO, recombinant full-length Kif18A (His-Kif18A FL ) immobilized on the surface of the glass slide moved fluorescently labeled microtubules at a speed of (0.036 AE 0.015) mm min À1 , consistent with previous reports [2] (Figure 2 b, c, and Movie S1 in the Supporting Information). Flushing-in 100 mm BTB-1 almost completely stopped the His-Kif18A FL -dependent Mt motility (Figure 2 b, c and Movie S2 in the Supporting Information). This effect was specific because 100 mm monastrol, a selective inhibitor of the mitotic kinesin Eg5, [5] did not affect HisKif18A FL -dependent motility ( 
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Kinesins hydrolyze ATP as they walk along microtubules, this shows ATP to be a genuine substrate and microtubules as pseudosubstrates that are not turned over by the enzyme. We investigated whether BTB-1 competes with ATP for Kif18A binding. Specifically, we determined the rate of Mt-stimulated ATP hydrolysis by His-Kif18A motor in the presence of saturating concentrations of Mts, varying concentrations of ATP and BTB-1, and fitted each set of data to the MichaelisMenten equation (see Supporting Information). As can be derived from Figure 3 a, BTB-1 increased the K m value for ATP while not significantly affecting the V max value. ATPgS, a non-hydrolyzable ATP-competitive analogue, similarly affected K m and V max (Figure 3 b) implying that BTB-1 inhibits Kif18A in an ATP-competitive manner.
Next, we analyzed how microtubules affect the inhibitory effect of BTB-1 on Kif18A. To this end, the rate of HisKif18A motor -mediated ATP hydrolysis in the presence of saturating ATP concentrations and varying concentrations of Mts and BTB-1 was quantified (Figure 3 c) . BTB-1 affected both the K1 = 2 value for Mts (for Mts as pseudosubstrates the term K1 = 2 instead of K m is used) and the V max value indicating that BTB-1 might act in a noncompetitive, uncompetitive, or mixed-competition manner. Detailed analyses of the Michaelis-Menten kinetics identified the uncompetitive mode of inhibition as the best-fitting model, thereby implying that BTB-1 binds only to the complex formed by Mt-bound Kif18A. If this applies, then BTB-1 would not be expected to inhibit the basal, microtubule-independent ATPase activity of Kif18A. To test this, we used an enzyme-coupled assay to measure the basal ATPase activity of recombinant HisKif18A motor before the addition of DMSO/BTB-1 (phase I), after the addition of DMSO/BTB-1 (phase II), or the stimulated ATPase activity of His-Kif18A motor upon addition of Mts in the presence of DMSO or BTB-1 (phase III). To be able to measure the low, Mt-independent ATPase activity of Kif18A, we had to use high concentrations of His-Kif18A (DMSO)) corroborating our model that the inhibitory activity of BTB-1 depends on the formation of complexes between Kif18A and Mts. Monastrol, consistent with previous reports, [6] inhibited both the basal and Mt-stimulated ATPase activity of Eg5 (Figure 3 e,g ). Collectively, these data imply that BTB-1 inhibits Kif18A in an ATP-competitive, Mt-uncompetitive manner.
We tested whether BTB-1 affects the mitotic progression of HeLa cells. RNA-interference (RNAi)-mediated depletion of Kif18A causes severe defects in spindle morphology accompanied by decisive failures in chromosome congression resulting in the accumulation of cells at an early stage of mitosis. [2, 7] Notably, HeLa cells treated with BTB-1 accumulated in mitosis in a dose-dependent manner (Figure 4 c) . Immunofluorescence images revealed that spindle structures were severely compromised in BTB-1 treated cells (Figure 4 b ). Yet, elongated spindles observed upon RNAimediated depletion of Kif18A [2] were not detectable in BTB-1 treated cells. However, the dual-functionality of Kif18A-it can move along Mts and depolymerize them at the tips-complicates the interpretation of phenotypes caused by unequal approaches, that is, removal of Kif18A from the cellular context by RNAi versus inhibition of its ATPase activity by BTB-1. Thus, further research efforts are required to unambiguously evaluate Kif18A as the relevant target of BTB-1 in cells.
In summary, we report herein the discovery of the first inhibitor of Kif18A, BTB-1, identified by a protein-based, reverse-chemical genetic screen. Detailed enzymatic studies revealed that BTB-1 is a potent inhibitor of Kif18A (IC 50 = 1.69 mm) that acts reversibly in an ATP-competitive and Mtuncompetitive manner, that is, BTB-1 competes with ATP for Kif18A binding only when the motor-protein is associated with its pseudosubstrate microtubules. This distinctive characteristic combined with its fast and reversible mode of inhibition makes BTB-1 a powerful tool to dissect the mechanochemical properties of Kif18A, a kinesin that integrates both microtubule motility and depolymerizing activity. Thus, our chemical-biology-based approach has provided access to a new tool for studying a protein key for motor activity during phase I, II, and III as described in (d); averages of three independent experiments and standard deviations are shown; the quantification of the buffer controls is omitted; red = DMSO, blue = BTB-1. g) Quantification of His-Eg5 motor activity, averages of three independent experiments and standard deviations are shown; the quantification of the buffer controls is omitted; red = DMSO, green = monastrol.
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Chemie chromosome segregation in mammalian cells. Examples of inhibitors of the mitotic kinesin Eg5, [5, [8] [9] [10] non-muscle myosin II, [11] and Polo-like (Plk1) [12] [13] [14] [15] or Aurora [16] kinases demonstrate that small molecules are not only invaluable probes for basic science, but can also open up new avenues in the treatment of mitosis-related diseases, such as cancer. Current efforts involve the analyses of the cellular effects of BTB-1. 
